Skip to content

CICATRIX in the Treatment of Recent Post-surgical Scars

Efficacy of CICATRIX (Asian Gotu Kola or Pennywort) in the Treatment of Recent Post-surgical Scars

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00991367
Enrollment
90
Registered
2009-10-08
Start date
2009-10-31
Completion date
2010-12-31
Last updated
2010-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-surgical Scars

Keywords

Post-surgical scars, Asian Gotu Kola, Asian Pennywort

Brief summary

The purpose of the study is to assess the efficacy of CICATRIX (Asian Gotu Kola or Pennywort) usage in the treatment of recent post-surgical scars. The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks. The estimated number of persons to be recruited and randomized for the study is 90.

Interventions

OTHERCicatrix

Dosage commensurate with surface to be treated. After washing and drying the affected area, a thin layer of CICATRIX (Topical use) will be applied on the lesion rubbing in different directions for 2 minutes, three times a day, for 4 weeks.

OTHERPlacebo

Dosage commensurate with surface to be treated. After washing and drying the affected area, a thin layer of PLACEBO (Topical use) will be applied on the lesion rubbing in different directions for 2 minutes, three times a day, for 4 weeks.

Sponsors

Catalysis SL
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Recent (less than 48 hours) post-surgical wound

Exclusion criteria

* Post-surgical wound with sepsis * Usage of steroids within 30 days * Malignant neoplastic conditions * Alcoholism * Handicap and/or psychiatric condition preventing treatment accomplishment.

Design outcomes

Primary

MeasureTime frame
Length of the post-surgical scar(s) measured by a millimetric ruler at week 4 (end of the treatment)4 weeks

Secondary

MeasureTime frame
Occurrence of adverse effects at week 4 (end of the treatment)4 weeks
Photographs of lesions at week 4 (end of the treatment)4 weeks

Countries

Cuba

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026